← Association for Accessible Medicines
FDANonrulemakingFDA-2020-D-1548

Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe; Draft Guidance for Industry; Availability

RIN
—
Last modified
Dec 13, 2022
Comment window
closed 1464d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Nov 30, 2020 and Nov 30, 2020. 0 other organizations filed here. The comment window closed 1464d ago.

What Association for Accessible Medicines filed (1)

Nov 30, 2020· Comment from The Association for Accessible Medicines (AAM)· FDA-2020-D-1548-0004

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2020-D-1548 "Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe".

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →